LakeShore Biopharma receives revised $0.06 per share buyout proposal

March 25, 2026 8:00 AM EDT Send to a Friend
LakeShore Biopharma Co., Ltd. (OTCPK: LSBCF; OTCPK: LSBWF) announced that its special board committee received a revised preliminary non-binding proposal ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login